At first blush, the Biden administration’s decision to support waiving international intellectual property protections for coronavirus vaccines seems like a laudable act of humanitarian largesse, but the waiver is really a wolf in sheep’s clothing. The change would do little to speed up the production and distribution of vaccines in the countries that need them most, and the long-term ramifications would chill innovation domestically and globally.
Sen. Elizabeth Warren (D-Mass.) recently revealed what many on the Left hope to accomplish through this waiver. "Special [IP] protections for drug companies are an even bigger issue than COVID-19 alone,” she stated. “I think it's time now for our trade negotiators to take leadership and actively set rules that lower drug costs for American families.”
Read Full Article »
